We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Axxam SpA Receives Funding for the Development of Compounds for Prevention Treatment of Disability in MS

News   Jul 20, 2011

 
Axxam SpA Receives Funding for the Development of Compounds for Prevention Treatment of Disability in MS
 
 
 

RELATED ARTICLES

Triple-negative Breast Cancers Can Adopt Reversible State That is Resistant to Chemotherapy

News

Researchers have discovered that triple-negative breast cancer (TNBC) cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather transiently turning on molecular pathways that protect the cells.

READ MORE

Combining CRISPR With Drug Discovery to Understand Treatment Efficacy

News

Researchers combine CRISPR gene-editing technology with drug discovery to understand why treatment works (or doesn’t).

READ MORE

Promising Molecules for Stabilizing Abnormal Proteins That Cause AL Amyloidosis

News

Scientists at Scripps Research have identified a group of small molecules that prevent structural changes to proteins that are at the root of AL amyloidosis, a progressive and often fatal disease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE